The increased prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease has turbocharged the increase in demand for polymers in drug delivery systems. With Biorchestra ...
Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...
Different drug delivery systems have been developed for the treatment of digestive tract diseases. Historically, this is one of the first fields where the rationale for the use of polymer ...
These hyperbranched materials are being evaluated as drug delivery devices, controlled microgel particles and ... monomer structure and comonomer composition has on polymerization rates and polymer ...
Researchers at Tel Aviv University have developed a new platform using polymeric nanoparticles to deliver drug pairs to specific cancer types, including skin cancer and breast cancer.
The global Drug Delivery Systems Market is poised for significant growth, with its valuation estimated to increase from USD 40.1 billion in 2022 to USD 71.6 billion by 2031, at a compound annual ...
Professor Olivia Merkel, Chair of Drug Delivery at LMU's Faculty of Chemistry ... The specific focus was on how changes in polymer structure and environmental conditions impact particle formation.